Finance

Lists
CHME34:BVMF
Cme Group Inc BDR
R$67.69
0.00%
(0.00) 1D
Jul 31, 4:56:00 PM GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for CHME34...
Open
R$64.57
High
R$68.18
Low
R$64.57
Mkt. cap
96.29B
Avg. vol.
581.00
Volume
26.00
52-wk high
R$84.34
52-wk low
R$57.88
No. of employees
4K
Open
R$64.57
High
R$68.18
Low
R$64.57
Mkt. cap
96.29B
Avg. vol.
581.00
Volume
26.00
52-wk high
R$84.34
52-wk low
R$57.88
No. of employees
4K
News stories
From sources across the web
Profile
CME Group Inc., headquartered in Chicago, Illinois, operates exchanges and provides clearing services for trading in financial derivatives such as futures contracts, options, and swaps. Its exchanges include the Chicago Mercantile Exchange, the Chicago Board of Trade, the New York Mercantile Exchange, and the Commodity Exchange. The company also owns 27% of S&P Dow Jones Indices. The company operates the Globex Trading System, an electronic trading platform that allows customers in approximately 150 countries to trade futures and options contracts. The company also operates two platforms for spot market trading: BrokerTec, which facilitates dealer-to-dealer trading in fixed-income products, and EBS, which provides spot trading in foreign exchange markets. CME Clearing serves as a counterparty to every transaction cleared by the company. Financial derivatives traded on CME's exchanges are tied to interest rates, stock market indexes, energy-related products, agricultural products, exchange currencies, metals, and cryptocurrency. Institutional trading represents 85% to 90% of the company's trading volume. Wikipedia
About Cme Group Inc BDR
CEOTerrence A. Duffy
Employees3.88K
FoundedJul 12, 2007
HeadquartersChicago, Illinois, United States
SectorCapital market
Websitecmegroup.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.53B
1.64B
1.88B
1.70B
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
440.00M
473.10M
446.60M
468.70M
Operating expense
561.80M
595.10M
566.50M
595.20M
Total operating expenses
561.80M
595.10M
566.50M
595.20M
Operating income
972.60M
1.05B
1.31B
1.11B
Other non operating income
-1.40B
-1.28B
-1.25B
-1.26B
EBT including unusual items
1.18B
1.58B
1.51B
1.33B
EBT excluding unusual items
1.18B
1.56B
1.51B
1.33B
Income tax expense
269.00M
395.50M
356.60M
285.90M
Effective tax rate
22.85%
25.06%
23.60%
21.53%
Other operating expenses
39.20M
39.60M
36.60M
42.30M
Net income
908.00M
1.18B
1.15B
1.04B
Net profit margin
59.18%
71.94%
61.52%
61.20%
Earnings per share
2.68
2.77
3.36
2.99
Interest and investment income
1.55B
1.78B
1.39B
1.43B
Interest expense
-44.00M
-43.70M
-43.60M
-43.60M
Net interest expenses
1.50B
1.73B
1.35B
1.39B
Depreciation and amortization charges
26.40M
26.50M
27.20M
28.20M
EBITDA
1.06B
1.13B
1.39B
1.19B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps